Browse/search for people

Dr Lorna Duncan

Dr Lorna Duncan

Dr Lorna Duncan
BSc (Coventry), PGCE, PhD (Imperial College London)

Qualitative Senior Research Associate for MAB Trial (Mistletoe & Breast Cancer)

Area of research

Lorna began working at the Centre of Academic Primary Care (CAPC) in March 2011. Her current research interests include: complementary therapies, the appropriate use of antibiotics, the use of pharmacogenetics in primary care and the optimisation of healthcare provision. Other research interests include: alternative therapies, community services and the measurement of quality in healthcare. Lorna is currently working on four studies. She is the qualitative researcher on the pilot study of the use of Mistletoe in Breast Cancer (MAB). The aim of this study is to find whether mistletoe helps to alleviate the side effects of chemotherapy in patients with breast cancer. It is widely used in Germany, the Netherlands and Switzerland. Lorna is also the qualitative researcher on the RAPID-TEST study. The RAPID-TEST is used to measure the levels of bacteria and viruses in patients visiting their GP with an upper respiratory tract infection (URTI). The aim of this pilot study is to see whether it is helpful in diagnosing and treating URTIs. Lorna is also working on two reviews. One of these is a systematic review of the evidence available to support the use of pharmacogenetic testing in treatment decisions in primary care eg whether knowing a person’s genetic make-up can help GPs to prescribe an appropriate medication, at an appropriate dose.The other is a rapid review of the effectiveness of the new Primary Care hubs which are being used in England to give patients improved access to GPs.

Office 1.08
Canynge Hall,
39 Whatley Road, Bristol BS8 2PS
(See a map)

+44 (0) 117 3314561

Summary

Biography

After graduating from the University of Coventry in 1990, with one year spent in the Netherlands investigating the regulation of P450 isoenzymes in relation to ageing, Lorna began work at St Mary’s Hospital Medical School, London. She studied the regulation of enzymes involved in oestrogen production in hormone-dependent breast cancer, and gained her PhD from Imperial College in 1996.  She then completed her PGCE in secondary science at Roehampton Institute London, and has since taught at secondary schools, as well as at FE and HE levels. Aside from Biology she has taught on a ‘Widening Participation (Science)' course at the University of Bath; and the Open University ‘Perspectives in Complementary and Alternative Medicine’ course. She has also taught children with visual impairment and other physical and learning disabilities.

When teaching at Kingston College, Lorna co-designed a course in complementary medicine and her interest in this field developed. She decided to study for a Diploma in Naturopathic Medicine with modules including herbal medicine, Chinese medicine, ear acupuncture, hydrotherapy, iridology, Bach flower therapy and hydrotherapy, and with a specialism in homoeopathy. She has also studied kinesiology. Subsequent to this, Lorna decided to return to research with a particular focus on CAM and medicines optimisation.   

Activities / Findings

Lorna began working at the Centre of Academic Primary Care (CAPC) in March 2011. Her current research interests include: complementary therapies, the appropriate use of antibiotics, the use of pharmacogenetics in primary care and the optimisation of healthcare provision. Other research interests include: alternative therapies, community services and the measurement of quality in healthcare.

Lorna is currently working on four studies. She is the qualitative researcher on the pilot study of the use of Mistletoe in Breast Cancer (MAB). The aim of this study is to find whether mistletoe helps to alleviate the side effects of chemotherapy in patients with breast cancer. It is widely used in Germany, the Netherlands and Switzerland.

Lorna is also the qualitative researcher on the RAPID-TEST study. The RAPID-TEST is used to measure the levels of bacteria and viruses in patients visiting their GP with an upper respiratory tract infection (URTI). The aim of this pilot study is to see whether it is helpful in diagnosing and treating URTIs.

Lorna is also working on two reviews. One of these is a systematic review of the evidence available to support the use of pharmacogenetic testing in treatment decisions in primary care eg whether knowing a person’s genetic make-up can help GPs to prescribe an appropriate medication, at an appropriate dose. The other is a rapid review of the effectiveness of the new Primary Care hubs which are being used in England to give patients improved access to GPs.

Memberships

Organisations

Bristol Medical School (PHS)

Centres, collaborations and units

Recent publications

View complete publications list in the University of Bristol publications system

Edit this profile If you are Dr Lorna Duncan, you can edit this page. Login required.

PDF versionDownload PDF